. Short-term administration of selegiline for mild-to-moderate dementia of the Alzheimer's type. Am J Geriatr Psychiatry. 1998 Spring;6(2):145-54. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. The abstract tells us that there was no drug-plecebo difference in any outcome measure, as had been seen in an earlier study 'perhaps because the patients were studied less intensively'.

Make a Comment

To make a comment you must login or register.